Chemicals & Petrochemicals
Valuation | |
|---|---|
| Market Cap | 3.3 kCr |
| Price/Earnings (Trailing) | -109.18 |
| Price/Sales (Trailing) | 1.85 |
| EV/EBITDA | 21.51 |
| Price/Free Cashflow | -231.97 |
| MarketCap/EBT | 129.16 |
| Enterprise Value | 3.85 kCr |
Fundamentals | |
|---|---|
Growth & Returns | |
|---|---|
| Price Change 1W | 21.4% |
| Price Change 1M | 20.1% |
| Price Change 6M | -27.9% |
| Price Change 1Y | 28.7% |
| 3Y Cumulative Return | 4.9% |
| 5Y Cumulative Return | 9% |
| 7Y Cumulative Return | 20.8% |
| 10Y Cumulative Return | 5.3% |
| Revenue (TTM) |
| 1.78 kCr |
| Rev. Growth (Yr) | 6.7% |
| Earnings (TTM) | -32.99 Cr |
| Earnings Growth (Yr) | 87.1% |
Profitability | |
|---|---|
| Operating Margin | 2% |
| EBT Margin | 1% |
| Return on Equity | -3.84% |
| Return on Assets | -1.62% |
| Free Cashflow Yield | -0.43% |
Cash Flow & Liquidity |
|---|
| Cash Flow from Investing (TTM) | -75.35 Cr |
| Cash Flow from Operations (TTM) | 26.72 Cr |
| Cash Flow from Financing (TTM) | 72.44 Cr |
| Cash & Equivalents | 87.44 Cr |
| Free Cash Flow (TTM) | -15.72 Cr |
| Free Cash Flow/Share (TTM) | -0.84 |
Balance Sheet | |
|---|---|
| Total Assets | 2.04 kCr |
| Total Liabilities | 1.18 kCr |
| Shareholder Equity | 860.12 Cr |
| Current Assets | 1.17 kCr |
| Current Liabilities | 856.38 Cr |
| Net PPE | 630.01 Cr |
| Inventory | 530.95 Cr |
| Goodwill | 47.47 Cr |
Capital Structure & Leverage | |
|---|---|
| Debt Ratio | 0.32 |
| Debt/Equity | 0.75 |
| Interest Coverage | -0.7 |
| Interest/Cashflow Ops | 1.29 |
Dividend & Shareholder Returns | |
|---|---|
| Dividend Yield | 0.15% |
| Shares Dilution (1Y) | 12.2% |
| Shares Dilution (3Y) | 19.7% |
Smart Money: Smart money is taking extra interest in the stock as they increase their holdings.
Balance Sheet: Reasonably good balance sheet.
Momentum: Stock price has a strong positive momentum. Stock is up 20.1% in last 30 days.
Past Returns: In past three years, the stock has provided 4.9% return compared to 12.8% by NIFTY 50.
Dilution: Company has a tendency to dilute it's stock investors.
Smart Money: Smart money is taking extra interest in the stock as they increase their holdings.
Balance Sheet: Reasonably good balance sheet.
Momentum: Stock price has a strong positive momentum. Stock is up 20.1% in last 30 days.
Past Returns: In past three years, the stock has provided 4.9% return compared to 12.8% by NIFTY 50.
Dilution: Company has a tendency to dilute it's stock investors.
Investor Care | |
|---|---|
| Dividend Yield | 0.15% |
| Shares Dilution (1Y) | 12.2% |
| Earnings/Share (TTM) | -1.57 |
Financial Health | |
|---|---|
| Current Ratio | 1.36 |
| Debt/Equity | 0.75 |
Technical Indicators | |
|---|---|
| RSI (14d) | 65.91 |
| RSI (5d) | 90.13 |
| RSI (21d) | 63.12 |
| MACD Signal | Buy |
| Stochastic Oscillator Signal | Hold |
| SharesGuru Signal | Buy |
| RSI Signal | Hold |
| RSI5 Signal | Sell |
| RSI21 Signal | Hold |
| SMA 5 Signal | Buy |
| SMA 10 Signal | Buy |
| SMA 20 Signal | Buy |
| SMA 50 Signal | Buy |
| SMA 100 Signal | Buy |
Summary of Camlin Fine Sciences's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.
The management of Camlin Fine Sciences provided a positive outlook during the earnings call for Q2 and H1 FY'26, emphasizing growth across various verticals despite challenges such as tariff pressures impacting realizations.
Key forward-looking points include:
Revenue Guidance: Management reiterated its sales goal of approximately Rs. 2,000 to Rs. 2,100 crores for the fiscal year, remaining confident in meeting this target.
Vanillin and Blends Performance: For the Vanillin segment, management estimated reaching 2,500 tons to 3,000 tons for the fiscal year, citing a year-to-date performance of roughly 1,300 tons. The blends business is expected to grow at an annual rate of 18% to 20%, supported by workforce expansion and ongoing acquisitions.
EBITDA Projection: The EBITDA for the quarter stood at Rs. 33 crores, reflecting improved operational performance. Management expects this trend to continue as they achieve better capacity utilization in their plants.
Tariff Impact: The management indicated that the current tariff of 50% on exports to the US has pressured realizations, but they expect to see improvements if tariffs are reduced. Realizations on US contracts are projected to improve as they navigate the tariff situation.
Operational Investments: The company has strengthened its marketing and sales teams, adding approximately 31 employees to enhance its blend business capabilities and expected to see impacts from this expansion starting in Q4.
Cost Management: Costs remained stable despite the increase in employee expenses, attributed to strategic hiring to build capacity in a growing segment.
Market Position: The management expressed confidence in their strategic positioning in key markets and anticipated significant contributions from recent acquisitions expected to integrate fully by the end of November.
Overall, management conveyed a robust position going forward, focusing on growth amidst operational challenges and strategic expansions.
Understand Camlin Fine Sciences ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.
| Shareholder Name | Holding % |
|---|---|
| Ashish Subhash Dandekar | 10.3% |
| Infinity Direct Holdings | 10.18% |
| Anfima Nv | 8.83% |
| Infinity Holdings | 6.2% |
| Infinity Direct Capital | 4.82% |
| Icici Prudential Commodities Fund | 4.03% |
| Camart Finance Limited | 2.77% |
Detailed comparison of Camlin Fine Sciences against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.
Ticker | Name | Mkt Cap | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|---|
| VINATIORGA | Vinati Organics | 15.87 kCr | 2.31 kCr | -5.20% | -13.60% | 35.83 | 6.87 | - | - |
| JUBLINGREA | Jubilant Ingrevia |
Comprehensive comparison against sector averages
CAMLINFINE metrics compared to Chemicals
| Category | CAMLINFINE | Chemicals |
|---|---|---|
| PE | -112.76 | 44.71 |
| PS | 1.92 | 4.17 |
| Growth | 9.3 % | 6.2 % |
This is an informational page just to provide a quick 'first look' at the stock. You must do your own deeper research. Know your risk appetite. Consult a SEBI-registered financial advisor before making any investment decisions.
CAMLINFINE vs Chemicals (2021 - 2026)
Rehan: "Could you help us understand how is the channel looking currently? Is the de-stocking complete?"
Nirmal Momaya: "The de-stocking in the US is expected to be completed by Q4 of this year. In Europe, it should clear by Q1 of FY'27 due to anti-dumping duties starting in July."
Rehan: "What would have been your blended realization around for this quarter?"
Nirmal Momaya: "Our blended realization was around $12, net of freight and other costs, varying between $11 and $12."
Rehan: "Are we confident of reiterating guidance for 2,500 tons-3,000 tons for Vanillin this year?"
Nirmal Momaya: "Yes, we've already achieved almost 1,300 tons in H1, and we are confident in maintaining our guidance for both Vanillin and Blends, aiming for 18%-20% growth."
Satish Kumar: "Will you achieve the guidance of around Rs. 2,000-Rs. 2,100 crores in sales?"
Nirmal Momaya: "Yes, we are on track to meet the Rs. 2,000-Rs. 2,100 crores sales target."
Surya Narayan Patra: "What is impacting the North American business?"
Nirmal Momaya: "There was a slowdown in the pet food sector, but it is picking up again. Pricing changes and tariffs also affected our performance."
Raj Agrawal: "How long will European losses continue?"
Santosh Parab: "We expect quarterly losses to average around Rs. 5-6 crores this year, reducing to Rs. 2 crores per quarter next year."
Niraj: "If tariffs are reduced, how quick will the realization improve?"
Nirmal Momaya: "For DDP contracts, realization will improve immediately after tariffs drop. For CIF contracts, it depends on contract renewal timings."
| Franklin India Opportunites Fund | 2.46% |
| Nirmal Vinod Momaya | 1.88% |
| Anagha Subhash Dandekar | 1.57% |
| Vibha Agencies Pvt Ltd | 1.36% |
| Ajay Upadhyaya | 1.29% |
| Infinity Portfolio Holdings | 1.17% |
| Sixteenth Street Asian Gems Fund | 1.06% |
| Cafco Consultants Limited | 0.78% |
| Radha Pandit | 0.04% |
| Anand Y Pandit | 0.01% |
| MK Falcon Agro tech Pvt. Ltd. | 0% |
Distribution across major stakeholders
Distribution across major institutional holders
| 9.97 kCr |
| 4.3 kCr |
| -15.80% |
| -15.80% |
| 37.24 |
| 2.32 |
| - |
| - |
| GALAXYSURF | Galaxy Surfactants | 6.48 kCr | 4.82 kCr | -8.10% | -25.00% | 22.64 | 1.35 | - | - |
| SEQUENT | Sequent Scientific | 5.26 kCr | 1.67 kCr | +1.00% | +27.20% | 125.3 | 3.15 | - | - |
| BALAMINES | Balaji Amines | 3.58 kCr | 1.41 kCr | +3.10% | -36.40% | 24.98 | 2.54 | - | - |
| 437 |
| 413 |
| 433 |
| 427 |
| 421 |
| Profit Before exceptional items and Tax | 88.1% | 0.27 | -5.15 | 34 | 1.52 | 8.23 | -23.48 |
| Exceptional items before tax | - | 0 | 0 | -5.59 | 0 | -151.04 | 0 |
| Total profit before tax | 88.1% | 0.27 | -5.15 | 29 | 1.52 | -142.81 | -23.48 |
| Current tax | -7.4% | 5.61 | 5.98 | 14 | 4.32 | 16 | 7.4 |
| Deferred tax | 90% | 0.3 | -5.99 | -6.04 | 2.82 | -42.61 | 3.77 |
| Total tax | 586.1% | 5.91 | -0.01 | 7.95 | 7.14 | -26.2 | 11 |
| Total profit (loss) for period | -36.6% | -14.95 | -10.68 | 0.11 | -7.47 | -116.11 | -34.65 |
| Other comp. income net of taxes | -118% | -0.98 | 12 | 5.79 | -12.11 | 0.03 | -5.95 |
| Total Comprehensive Income | -6872% | -15.93 | 1.25 | 5.9 | -19.58 | -116.08 | -40.6 |
| Earnings Per Share, Basic | -15% | -0.76 | -0.53 | -0.04 | -0.243 | -5.98 | -2.03 |
| Earnings Per Share, Diluted | -15.8% | -0.76 | -0.52 | -0.04 | -0.24 | -5.93 | -2.01 |
| Debt equity ratio | - | - | - | 0.72 | - | - | 0 |
| Debt service coverage ratio | - | - | - | 0.01 | - | - | 0 |
| 9.2% |
| 72 |
| 66 |
| 60 |
| 53 |
| 39 |
| 28 |
| Finance costs | 22.6% | 66 | 54 | 57 | 33 | 33 | 28 |
| Depreciation and Amortization | 8.3% | 53 | 49 | 33 | 27 | 19 | 11 |
| Other expenses | 10.6% | 262 | 237 | 236 | 161 | 121 | 103 |
| Total Expenses | 10% | 935 | 850 | 752 | 668 | 590 | 559 |
| Profit Before exceptional items and Tax | 51.6% | -27.43 | -57.7 | 67 | 36 | 16 | 44 |
| Exceptional items before tax | -3210.6% | -96 | -1.93 | 0 | 0 | -0.5 | -3.14 |
| Total profit before tax | -105.2% | -123.43 | -59.63 | 67 | 36 | 15 | 41 |
| Current tax | - | 1.66 | 0 | 14 | 6.4 | 2.78 | 7.5 |
| Deferred tax | -438.7% | -48.78 | -8.24 | 5.15 | 3.81 | 3.96 | 3.06 |
| Total tax | -420.8% | -47.12 | -8.24 | 19 | 10 | 6.74 | 11 |
| Total profit (loss) for period | -47.6% | -76.31 | -51.39 | 48 | 26 | 8.28 | 31 |
| Other comp. income net of taxes | -48.1% | -0.54 | -0.04 | -0.66 | -0.15 | -0.38 | -0.29 |
| Total Comprehensive Income | -48.5% | -76.85 | -51.43 | 47 | 26 | 7.9 | 30 |
| Earnings Per Share, Basic | -32.3% | -4.41 | -3.09 | 3.18 | 1.98 | 0.67 | 2.53 |
| Earnings Per Share, Diluted | -32.3% | -4.36 | -3.05 | 3.14 | 1.94 | 0.6 | 2.53 |
| Debt equity ratio | - | 051 | 0 | 0 | 0 | 0 | 0 |
| Debt service coverage ratio | - | 077 | 0 | 0 | 0 | 0 | 0 |
| 13 |
| 9.1 |
| 24 |
| 31 |
| 35 |
| 207 |
| Investment property | 0% | 2.16 | 2.16 | 0 | 0 | 0 | 0 |
| Non-current investments | 4.8% | 67 | 64 | 64 | 80 | 82 | 82 |
| Loans, non-current | - | 0 | 0 | 0 | 4.69 | 12 | 6.8 |
| Total non-current financial assets | 9.1% | 73 | 67 | 67 | 88 | 98 | 95 |
| Total non-current assets | -0.3% | 697 | 699 | 706 | 711 | 724 | 625 |
| Total assets | -2.6% | 1,587 | 1,629 | 1,456 | 1,572 | 1,590 | 1,346 |
| Borrowings, non-current | 9.4% | 188 | 172 | 195 | 222 | 237 | 258 |
| Total non-current financial liabilities | 7.2% | 195 | 182 | 195 | 237 | 252 | 268 |
| Provisions, non-current | 25.5% | 6.42 | 5.32 | 5.44 | 4.97 | 4.65 | 3.32 |
| Total non-current liabilities | 7.5% | 201 | 187 | 214 | 249 | 272 | 282 |
| Borrowings, current | -19.3% | 218 | 270 | 313 | 269 | 244 | 190 |
| Total current financial liabilities | -6.5% | 530 | 567 | 565 | 580 | 506 | 442 |
| Provisions, current | 26% | 3.96 | 3.35 | 3.13 | 3.02 | 2.48 | 1.7 |
| Current tax liabilities | - | - | - | 0.01 | 0 | 6.25 | 5.62 |
| Total current liabilities | -6.7% | 541 | 580 | 613 | 607 | 546 | 472 |
| Total liabilities | -3.1% | 742 | 766 | 826 | 856 | 818 | 754 |
| Equity share capital | 0% | 19 | 19 | 17 | 17 | 17 | 16 |
| Total equity | -2.1% | 844 | 862 | 630 | 716 | 772 | 592 |
| Total equity and liabilities | -2.6% | 1,587 | 1,629 | 1,456 | 1,572 | 1,590 | 1,346 |
| -98.8% |
| 1.2 |
| 18 |
| 7.39 |
| 1.15 |
| - |
| - |
| Net Cashflows From Operating Activities | -74.1% | 22 | 82 | 19 | 47 | - | - |
| Cashflows used in obtaining control of subsidiaries | - | 0 | 0 | 0 | 6.55 | - | - |
| Cash payment for investment in partnership firm or association of persons or LLP | - | 31 | 0 | 0 | 0 | - | - |
| Proceeds from sales of PPE | 93.5% | 0.94 | 0.08 | 0 | 0 | - | - |
| Purchase of property, plant and equipment | -45% | 23 | 41 | 131 | 189 | - | - |
| Interest received | 87.5% | 0.94 | 0.52 | 0.65 | 1.61 | - | - |
| Other inflows (outflows) of cash | -305.9% | -34.72 | -7.8 | 29 | 28 | - | - |
| Net Cashflows From Investing Activities | -68.2% | -87.66 | -51.72 | -114.73 | -172.33 | - | - |
| Proceeds from issuing shares | - | 223 | 0 | 0 | 95 | - | - |
| Proceeds from exercise of stock options | -138.1% | 0 | 0.58 | 0.55 | 0 | - | - |
| Proceeds from borrowings | -107.7% | 0 | 14 | 121 | 88 | - | - |
| Repayments of borrowings | 14900% | 61 | 1.4 | 0 | 21 | - | - |
| Payments of lease liabilities | - | 7.73 | 0 | 3.98 | 2.25 | - | - |
| Interest paid | 15.2% | 54 | 47 | 39 | 31 | - | - |
| Net Cashflows from Financing Activities | 385.3% | 101 | -34.05 | 78 | 129 | - | - |
| Net change in cash and cash eq. | 828.1% | 35 | -3.67 | -17.82 | 3.39 | - | - |